SlideShare a Scribd company logo

JDRF at the Partnering for Cures Conference

•Download as PPT, PDF•
•
T
TRAIN Central Station

The Juvenile Diabetes Research Foundation (JDRF) aims to cure, treat, and prevent diabetes through funding research. It has funded over $1 billion in research over 39 years to find disease-modifying drugs and devices. JDRF partners with industry, academia, patients, and other organizations to fund early-stage, translational, and clinical research. Its highest priorities include beta cell therapies, immune therapies, artificial pancreas devices, and therapies to prevent complications.

Health & Medicine
1 of 15
Juvenile Diabetes Research Foundation (JDRF) www.jdrf.org
JDRF: Mission and General Strategy To find a cure for diabetes and its complications Proactively accelerate the discovery , developmen t, and delivery of disease-modifying drugs and devices to better treat and cure diabetes and its complications
Diabetes Market Landscape ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
JDRF: Support ,[object Object],[object Object],[object Object],[object Object],[object Object]
JDRF: Partners JDRF Venture Capital Industry People with Type 1 Diabetes Providers, Educators Academia Funders: NIH, Government, Foundations FDA Payers JDRF
JDRF: Support ,[object Object],[object Object]
JDRF: Diabetes Stage-Specific Focus Treat Prevent Prevent Treat Cure Established Diabetes Recent Onset Diabetes At-Risk
JDRF: Support ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
JDRF: R&D Strategy JDRF’s Role: To advance IP and product development by “de-risking”, increasing value, and filling gaps Patients ,[object Object],[object Object],Clinical Development Translational Research Basic Research
JDRF: Industry Partners- 1 EU FP Funding (through Phase I ) Immune Therapies Beta Cell Therapies
JDRF: Industry Partners- 2 Glucose Control Complication Therapies
GNF-JDRF Partnership: Filling a Critical Gap Deliver novel IND candidates for out-licensing or co-development with Novartis or other pharma  cell survival -Housey -GNF ,[object Object],[object Object], cell survival -Kafman -Nadler -Others ,[object Object],[object Object],[object Object],[object Object],[object Object],Reprogram. -Hecksher- Sorensen -Schreiber XOMA-052 -Survival Reprogram -Herrera -Ferber -Kay/Grompe -Bouwens -RFA pending Progenitor cells -Sander/ Cirulli -Ferrer -Bonner-Weir - Bouwens Cell Target Path- way Target ID Lead ID Lead Develop Lead Optim EIH Enable Clinical Proof of concept ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object], cell survival -Johnson -Zick-Others PPI/DPPIVi -Rabinovitch Gastrin therapy -Transition Leading Pharma Partners Leading Academic Partners
JDRF: Organizational Leadership ,[object Object],[object Object],[object Object],[object Object]
JDRF: Summary/Key Points ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Q&A

Recommended

Patient Input: What is asked for and what is helpful in a patient submission
Patient Input: What is asked for and what is helpful in a patient submissionPatient Input: What is asked for and what is helpful in a patient submission
Patient Input: What is asked for and what is helpful in a patient submission
Canadian Organization for Rare Disorders
 
The Impact of High Cost Oncology Drugs
The Impact of High Cost Oncology DrugsThe Impact of High Cost Oncology Drugs
The Impact of High Cost Oncology Drugs
Joshua Jacob
 
Cathy parker the orphan drug framework
Cathy parker the orphan drug frameworkCathy parker the orphan drug framework
Cathy parker the orphan drug framework
Canadian Organization for Rare Disorders
 
A Brief History of the CDFI
A Brief History of the CDFIA Brief History of the CDFI
A Brief History of the CDFI
Canadian Organization for Rare Disorders
 
Michael reilly toronto nov19presentation final
Michael reilly toronto nov19presentation finalMichael reilly toronto nov19presentation final
Michael reilly toronto nov19presentation final
Canadian Organization for Rare Disorders
 
Hirschfield Synopsis
Hirschfield SynopsisHirschfield Synopsis
Hirschfield Synopsis
Jeffrey Hirschfield MD CPI
 
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...Multidisciplinary teams for diagnosis and treatment of children (and adults) ...
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...
Canadian Organization for Rare Disorders
 
IRDiRC: progress and expectations
IRDiRC: progress and expectationsIRDiRC: progress and expectations
IRDiRC: progress and expectations
Canadian Organization for Rare Disorders
 

Recommended

Patient Input: What is asked for and what is helpful in a patient submission
Patient Input: What is asked for and what is helpful in a patient submissionPatient Input: What is asked for and what is helpful in a patient submission
Patient Input: What is asked for and what is helpful in a patient submission
Canadian Organization for Rare Disorders
 
The Impact of High Cost Oncology Drugs
The Impact of High Cost Oncology DrugsThe Impact of High Cost Oncology Drugs
The Impact of High Cost Oncology Drugs
Joshua Jacob
 
Cathy parker the orphan drug framework
Cathy parker the orphan drug frameworkCathy parker the orphan drug framework
Cathy parker the orphan drug framework
Canadian Organization for Rare Disorders
 
A Brief History of the CDFI
A Brief History of the CDFIA Brief History of the CDFI
A Brief History of the CDFI
Canadian Organization for Rare Disorders
 
Michael reilly toronto nov19presentation final
Michael reilly toronto nov19presentation finalMichael reilly toronto nov19presentation final
Michael reilly toronto nov19presentation final
Canadian Organization for Rare Disorders
 
Hirschfield Synopsis
Hirschfield SynopsisHirschfield Synopsis
Hirschfield Synopsis
Jeffrey Hirschfield MD CPI
 
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...Multidisciplinary teams for diagnosis and treatment of children (and adults) ...
Multidisciplinary teams for diagnosis and treatment of children (and adults) ...
Canadian Organization for Rare Disorders
 
IRDiRC: progress and expectations
IRDiRC: progress and expectationsIRDiRC: progress and expectations
IRDiRC: progress and expectations
Canadian Organization for Rare Disorders
 
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Canadian Organization for Rare Disorders
 
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?
Canadian Organization for Rare Disorders
 
Glenn Monteith expert patients forum
Glenn Monteith expert patients forumGlenn Monteith expert patients forum
Glenn Monteith expert patients forum
Canadian Organization for Rare Disorders
 
Digestive Diseases Week Highlights Premier Scientific Research
Digestive Diseases Week Highlights Premier Scientific ResearchDigestive Diseases Week Highlights Premier Scientific Research
Digestive Diseases Week Highlights Premier Scientific Research
Rajan Bhatt
 
Hepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart FlanaganHepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart Flanagan
ReShape
 
Case study cdr p cpa re kuvan for cord november 2015
Case study cdr p cpa re kuvan for cord november 2015Case study cdr p cpa re kuvan for cord november 2015
Case study cdr p cpa re kuvan for cord november 2015
Canadian Organization for Rare Disorders
 
JournalofCancerEpidemiologyandTreatment6
JournalofCancerEpidemiologyandTreatment6JournalofCancerEpidemiologyandTreatment6
JournalofCancerEpidemiologyandTreatment6
Christian Schmidt
 
Connecting the Dots for Fast-Track Approval for Rare Disease and Orphan Drug
Connecting the Dots for Fast-Track Approval for Rare Disease and Orphan DrugConnecting the Dots for Fast-Track Approval for Rare Disease and Orphan Drug
Connecting the Dots for Fast-Track Approval for Rare Disease and Orphan Drug
Medpace
 
Examining Models for a National Pharmacare Program
Examining Models for a National Pharmacare ProgramExamining Models for a National Pharmacare Program
Examining Models for a National Pharmacare Program
Canadian Cancer Survivor Network
 
Orphan Drug Designation
Orphan Drug DesignationOrphan Drug Designation
Orphan Drug Designation
National Alopecia Areata Foundation
 
Patient Centered Health Care Advocacy
Patient Centered Health Care AdvocacyPatient Centered Health Care Advocacy
Patient Centered Health Care Advocacy
Canadian Organization for Rare Disorders
 
Webinar 3: Alternative Approaches to Innovative Drug Pricing
Webinar 3: Alternative Approaches to Innovative Drug PricingWebinar 3: Alternative Approaches to Innovative Drug Pricing
Webinar 3: Alternative Approaches to Innovative Drug Pricing
Canadian Organization for Rare Disorders
 
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Canadian Organization for Rare Disorders
 
Diabetic Foot Ulcer (DFU) Pipeline Analysis
Diabetic Foot Ulcer (DFU) Pipeline AnalysisDiabetic Foot Ulcer (DFU) Pipeline Analysis
Diabetic Foot Ulcer (DFU) Pipeline Analysis
Vinay Shiva Prasad
 
Legacy Healthcare and Alopecia Areata Program Overview
Legacy Healthcare and Alopecia Areata Program OverviewLegacy Healthcare and Alopecia Areata Program Overview
Legacy Healthcare and Alopecia Areata Program Overview
National Alopecia Areata Foundation
 
Webinar: Healthcare in the Federal Budget and How It May Affect Patients
Webinar: Healthcare in the Federal Budget and How It May Affect Patients Webinar: Healthcare in the Federal Budget and How It May Affect Patients
Webinar: Healthcare in the Federal Budget and How It May Affect Patients
Canadian Cancer Survivor Network
 
Rules of Engagement in Drug Development: Activating the Patient Voice
Rules of Engagement in Drug Development: Activating the Patient VoiceRules of Engagement in Drug Development: Activating the Patient Voice
Rules of Engagement in Drug Development: Activating the Patient Voice
National Alopecia Areata Foundation
 
Webinar 1: Patients Speak Out
Webinar 1: Patients Speak Out Webinar 1: Patients Speak Out
Webinar 1: Patients Speak Out
Canadian Organization for Rare Disorders
 
Durhane: Rare Drug Strategy Webinar
Durhane: Rare Drug Strategy WebinarDurhane: Rare Drug Strategy Webinar
Durhane: Rare Drug Strategy Webinar
Canadian Organization for Rare Disorders
 
Building an Ecosystem to Enable, Encourage and Support New Products for AA
Building an Ecosystem to Enable, Encourage and Support New Products for AABuilding an Ecosystem to Enable, Encourage and Support New Products for AA
Building an Ecosystem to Enable, Encourage and Support New Products for AA
National Alopecia Areata Foundation
 
BIO 2010 Partnering with Patients
BIO 2010 Partnering with PatientsBIO 2010 Partnering with Patients
BIO 2010 Partnering with Patients
TRAIN Central Station
 
BIO 2010 Partnering with Patients
BIO 2010 Partnering with PatientsBIO 2010 Partnering with Patients
BIO 2010 Partnering with Patients
TRAIN Central Station
 

More Related Content

What's hot

Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Canadian Organization for Rare Disorders
 
JournalofCancerEpidemiologyandTreatment6
JournalofCancerEpidemiologyandTreatment6JournalofCancerEpidemiologyandTreatment6
JournalofCancerEpidemiologyandTreatment6
Christian Schmidt
 
Connecting the Dots for Fast-Track Approval for Rare Disease and Orphan Drug
Connecting the Dots for Fast-Track Approval for Rare Disease and Orphan DrugConnecting the Dots for Fast-Track Approval for Rare Disease and Orphan Drug
Connecting the Dots for Fast-Track Approval for Rare Disease and Orphan Drug
Medpace
 
Webinar 3: Alternative Approaches to Innovative Drug Pricing
Webinar 3: Alternative Approaches to Innovative Drug PricingWebinar 3: Alternative Approaches to Innovative Drug Pricing
Webinar 3: Alternative Approaches to Innovative Drug Pricing
Canadian Organization for Rare Disorders
 

What's hot (20)

Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
 
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?
Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?
 
Glenn Monteith expert patients forum
Glenn Monteith expert patients forumGlenn Monteith expert patients forum
Glenn Monteith expert patients forum
 
Digestive Diseases Week Highlights Premier Scientific Research
Digestive Diseases Week Highlights Premier Scientific ResearchDigestive Diseases Week Highlights Premier Scientific Research
Digestive Diseases Week Highlights Premier Scientific Research
 
Hepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart FlanaganHepatitis C Generic Drugs - Stuart Flanagan
Hepatitis C Generic Drugs - Stuart Flanagan
 
Case study cdr p cpa re kuvan for cord november 2015
Case study cdr p cpa re kuvan for cord november 2015Case study cdr p cpa re kuvan for cord november 2015
Case study cdr p cpa re kuvan for cord november 2015
 
JournalofCancerEpidemiologyandTreatment6
JournalofCancerEpidemiologyandTreatment6JournalofCancerEpidemiologyandTreatment6
JournalofCancerEpidemiologyandTreatment6
 
Connecting the Dots for Fast-Track Approval for Rare Disease and Orphan Drug
Connecting the Dots for Fast-Track Approval for Rare Disease and Orphan DrugConnecting the Dots for Fast-Track Approval for Rare Disease and Orphan Drug
Connecting the Dots for Fast-Track Approval for Rare Disease and Orphan Drug
 
Examining Models for a National Pharmacare Program
Examining Models for a National Pharmacare ProgramExamining Models for a National Pharmacare Program
Examining Models for a National Pharmacare Program
 
Orphan Drug Designation
Orphan Drug DesignationOrphan Drug Designation
Orphan Drug Designation
 
Patient Centered Health Care Advocacy
Patient Centered Health Care AdvocacyPatient Centered Health Care Advocacy
Patient Centered Health Care Advocacy
 
Webinar 3: Alternative Approaches to Innovative Drug Pricing
Webinar 3: Alternative Approaches to Innovative Drug PricingWebinar 3: Alternative Approaches to Innovative Drug Pricing
Webinar 3: Alternative Approaches to Innovative Drug Pricing
 
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
 
Diabetic Foot Ulcer (DFU) Pipeline Analysis
Diabetic Foot Ulcer (DFU) Pipeline AnalysisDiabetic Foot Ulcer (DFU) Pipeline Analysis
Diabetic Foot Ulcer (DFU) Pipeline Analysis
 
Legacy Healthcare and Alopecia Areata Program Overview
Legacy Healthcare and Alopecia Areata Program OverviewLegacy Healthcare and Alopecia Areata Program Overview
Legacy Healthcare and Alopecia Areata Program Overview
 
Webinar: Healthcare in the Federal Budget and How It May Affect Patients
Webinar: Healthcare in the Federal Budget and How It May Affect Patients Webinar: Healthcare in the Federal Budget and How It May Affect Patients
Webinar: Healthcare in the Federal Budget and How It May Affect Patients
 
Rules of Engagement in Drug Development: Activating the Patient Voice
Rules of Engagement in Drug Development: Activating the Patient VoiceRules of Engagement in Drug Development: Activating the Patient Voice
Rules of Engagement in Drug Development: Activating the Patient Voice
 
Webinar 1: Patients Speak Out
Webinar 1: Patients Speak Out Webinar 1: Patients Speak Out
Webinar 1: Patients Speak Out
 
Durhane: Rare Drug Strategy Webinar
Durhane: Rare Drug Strategy WebinarDurhane: Rare Drug Strategy Webinar
Durhane: Rare Drug Strategy Webinar
 
Building an Ecosystem to Enable, Encourage and Support New Products for AA
Building an Ecosystem to Enable, Encourage and Support New Products for AABuilding an Ecosystem to Enable, Encourage and Support New Products for AA
Building an Ecosystem to Enable, Encourage and Support New Products for AA
 

Similar to JDRF at the Partnering for Cures Conference

Primary biliary cholangitis (PBC) Epidemiology and Compitive landscape_Thelan...
Primary biliary cholangitis (PBC) Epidemiology and Compitive landscape_Thelan...Primary biliary cholangitis (PBC) Epidemiology and Compitive landscape_Thelan...
Primary biliary cholangitis (PBC) Epidemiology and Compitive landscape_Thelan...
Thelansis
 
standards-of-care-2022-ADA.pdf
standards-of-care-2022-ADA.pdfstandards-of-care-2022-ADA.pdf
standards-of-care-2022-ADA.pdf
phambang8
 

Similar to JDRF at the Partnering for Cures Conference (20)

BIO 2010 Partnering with Patients
BIO 2010 Partnering with PatientsBIO 2010 Partnering with Patients
BIO 2010 Partnering with Patients
 
BIO 2010 Partnering with Patients
BIO 2010 Partnering with PatientsBIO 2010 Partnering with Patients
BIO 2010 Partnering with Patients
 
Islet Investor Presentation Oct 2016 Global Online Growth Conference
Islet Investor Presentation Oct 2016 Global Online Growth ConferenceIslet Investor Presentation Oct 2016 Global Online Growth Conference
Islet Investor Presentation Oct 2016 Global Online Growth Conference
 
Chicagoresearchroundtablepresentationfinalversion 110707151020-phpapp02
Chicagoresearchroundtablepresentationfinalversion 110707151020-phpapp02Chicagoresearchroundtablepresentationfinalversion 110707151020-phpapp02
Chicagoresearchroundtablepresentationfinalversion 110707151020-phpapp02
 
MJFF Strategy for Accelerating Development of Parkinson’s Therapies
MJFF Strategy for Accelerating Development of Parkinson’s TherapiesMJFF Strategy for Accelerating Development of Parkinson’s Therapies
MJFF Strategy for Accelerating Development of Parkinson’s Therapies
 
2019 diabete
2019 diabete2019 diabete
2019 diabete
 
2019 ADA standards of medical care in diabetes
2019 ADA standards of medical care in diabetes2019 ADA standards of medical care in diabetes
2019 ADA standards of medical care in diabetes
 
ADA 2019 DIABETES AMERICAN DIABETES ASOCIATION
ADA 2019 DIABETES AMERICAN DIABETES ASOCIATION ADA 2019 DIABETES AMERICAN DIABETES ASOCIATION
ADA 2019 DIABETES AMERICAN DIABETES ASOCIATION
 
Ascendis Pharma Investment Presentation
Ascendis Pharma Investment PresentationAscendis Pharma Investment Presentation
Ascendis Pharma Investment Presentation
 
Webinar: Learnings and Unresolved Issues
Webinar: Learnings and Unresolved IssuesWebinar: Learnings and Unresolved Issues
Webinar: Learnings and Unresolved Issues
 
Ada 2018
Ada 2018Ada 2018
Ada 2018
 
Fibrous Dysplasia and McCune-Albright Syndrome
Fibrous Dysplasia and McCune-Albright SyndromeFibrous Dysplasia and McCune-Albright Syndrome
Fibrous Dysplasia and McCune-Albright Syndrome
 
Nestlé Health Science in the USA
Nestlé Health Science in the USANestlé Health Science in the USA
Nestlé Health Science in the USA
 
Primary biliary cholangitis (PBC) Epidemiology and Compitive landscape_Thelan...
Primary biliary cholangitis (PBC) Epidemiology and Compitive landscape_Thelan...Primary biliary cholangitis (PBC) Epidemiology and Compitive landscape_Thelan...
Primary biliary cholangitis (PBC) Epidemiology and Compitive landscape_Thelan...
 
standards-of-care-2022-ADA.pdf
standards-of-care-2022-ADA.pdfstandards-of-care-2022-ADA.pdf
standards-of-care-2022-ADA.pdf
 
Webinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
Webinar: Investing $1.5b in A Sustainable Rare Disease EcosystemWebinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
Webinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
 
ESTANDARES Diabetes ada 2018 dc 41
ESTANDARES Diabetes ada 2018 dc 41 ESTANDARES Diabetes ada 2018 dc 41
ESTANDARES Diabetes ada 2018 dc 41
 
ORPHAN DRUGS - Dr. Vikram.ppt
ORPHAN DRUGS - Dr. Vikram.pptORPHAN DRUGS - Dr. Vikram.ppt
ORPHAN DRUGS - Dr. Vikram.ppt
 
Connecting the Dots for Rare Disease Studies
Connecting the Dots for Rare Disease StudiesConnecting the Dots for Rare Disease Studies
Connecting the Dots for Rare Disease Studies
 
Rick Thompson findacure crdn summit 2017
Rick Thompson findacure crdn summit 2017Rick Thompson findacure crdn summit 2017
Rick Thompson findacure crdn summit 2017
 

More from TRAIN Central Station

More from TRAIN Central Station (13)

Valley of Death CAN Briefing Slides
Valley of Death CAN Briefing SlidesValley of Death CAN Briefing Slides
Valley of Death CAN Briefing Slides
 
Pharma Assets Portal
Pharma Assets PortalPharma Assets Portal
Pharma Assets Portal
 
Valley of Death Panel Slides at the Partnering for Cures Conference, December...
Valley of Death Panel Slides at the Partnering for Cures Conference, December...Valley of Death Panel Slides at the Partnering for Cures Conference, December...
Valley of Death Panel Slides at the Partnering for Cures Conference, December...
 
Progeria Research Foundation at Partnering for Cures
Progeria Research Foundation at Partnering for CuresProgeria Research Foundation at Partnering for Cures
Progeria Research Foundation at Partnering for Cures
 
PATH Malaria Vaccine Initiative
PATH Malaria Vaccine InitiativePATH Malaria Vaccine Initiative
PATH Malaria Vaccine Initiative
 
Life Raft Group: A New Model for Cancer Research
Life Raft Group: A New Model for Cancer ResearchLife Raft Group: A New Model for Cancer Research
Life Raft Group: A New Model for Cancer Research
 
Leukemia Lymphoma Society: An Invitation to Innovation
Leukemia Lymphoma Society: An Invitation to InnovationLeukemia Lymphoma Society: An Invitation to Innovation
Leukemia Lymphoma Society: An Invitation to Innovation
 
Susan G. Komen for the Cure Presentation at Partnering for Cures
Susan G. Komen for the Cure Presentation at Partnering for CuresSusan G. Komen for the Cure Presentation at Partnering for Cures
Susan G. Komen for the Cure Presentation at Partnering for Cures
 
IAVI's Integrated R&D Program: Accelerating AIDS vaccine development
IAVI's Integrated R&D Program: Accelerating AIDS vaccine developmentIAVI's Integrated R&D Program: Accelerating AIDS vaccine development
IAVI's Integrated R&D Program: Accelerating AIDS vaccine development
 
FasterCures Presentation at LifeFest 2008
FasterCures Presentation at LifeFest 2008FasterCures Presentation at LifeFest 2008
FasterCures Presentation at LifeFest 2008
 
FasterCures Presentation: Fostering innovation while delivering treatments an...
FasterCures Presentation: Fostering innovation while delivering treatments an...FasterCures Presentation: Fostering innovation while delivering treatments an...
FasterCures Presentation: Fostering innovation while delivering treatments an...
 
DNDi: New Drugs for Neglected Diseases; New Hope for Forgotten Patients
DNDi: New Drugs for Neglected Diseases; New Hope for Forgotten PatientsDNDi: New Drugs for Neglected Diseases; New Hope for Forgotten Patients
DNDi: New Drugs for Neglected Diseases; New Hope for Forgotten Patients
 
TB Alliance: Improving Treatments Against TB
TB Alliance: Improving Treatments Against TBTB Alliance: Improving Treatments Against TB
TB Alliance: Improving Treatments Against TB
 

Recently uploaded

Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
karishmasinghjnh
 
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service AvailableTrichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
GENUINE ESCORT AGENCY
 
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
jennyeacort
 
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Dipal Arora
 
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Anamika Rawat
 
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
parulsinha
 
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Dipal Arora
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
parulsinha
 
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
vidya singh
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
tanya dube
 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
GENUINE ESCORT AGENCY
 
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
GENUINE ESCORT AGENCY
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
aartirawatdelhi
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
chandars293
 
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
khalifaescort01
 
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
chetankumar9855
 
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Anamika Rawat
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Ishani Gupta
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
chandars293
 

Recently uploaded (20)

Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
 
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service AvailableTrichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
 
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
 
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
 
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
 
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
 
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
 
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
 
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
 
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
 
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
 
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
 
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
 

JDRF at the Partnering for Cures Conference

  • 1. Juvenile Diabetes Research Foundation (JDRF) www.jdrf.org
  • 2. JDRF: Mission and General Strategy To find a cure for diabetes and its complications Proactively accelerate the discovery , developmen t, and delivery of disease-modifying drugs and devices to better treat and cure diabetes and its complications
  • 3.
  • 4.
  • 5. JDRF: Partners JDRF Venture Capital Industry People with Type 1 Diabetes Providers, Educators Academia Funders: NIH, Government, Foundations FDA Payers JDRF
  • 6.
  • 7. JDRF: Diabetes Stage-Specific Focus Treat Prevent Prevent Treat Cure Established Diabetes Recent Onset Diabetes At-Risk
  • 8.
  • 9.
  • 10. JDRF: Industry Partners- 1 EU FP Funding (through Phase I ) Immune Therapies Beta Cell Therapies
  • 11. JDRF: Industry Partners- 2 Glucose Control Complication Therapies
  • 12.
  • 13.
  • 14.
  • 15. Q&A

Editor's Notes

  1. Gap Slide – describe key area JDRF is playing. Pat, are there any IDDP opportunities for later stage targets (i.e. IRS2?)